51
Participants
Start Date
October 31, 2016
Primary Completion Date
July 4, 2017
Study Completion Date
August 28, 2017
Vadadustat
Placebo
Aichi
Chiba
Ehime
Gunma
Hiroshima
Hokkaido
Hyōgo
Ibaraki
Kanagawa
Nagano
Nara
Niigata
Okayama
Okinawa
Osaka
Ōita
Shiga
Tokushima
Lead Sponsor
Akebia Therapeutics
INDUSTRY